Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Patients arriving at hospital emergency departments with acute ankle sprains can expect more timely advice and follow-up care in future after researchers in Oxford developed a new tool that will aid clinical decisions on treatment.

Hands holding a foot with the ankle coloured red to show a sprain

Ankle sprains are very common and represent up to 5% of all A&E admissions in the UK; between 20% and 30% of those patients are still struggling with pain and mobility issues nine months later.

The researchers at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) at the University of Oxford, supported by the NIHR Oxford Biomedical Research Centre and the NIHR's Health Technology Assessment programme, aimed to develop a prognostic model for identifying those people at a higher risk of poor outcome after an acute ankle sprain.

Their study on the SPRAINED (Synthesising a clinical Prognostic Rule for Ankle Injuries in the Emergency Department) prognostic model was published in the open access BMJ Open journal on Tuesday 6 November.

Dr David Keene of NDORMS, who was part of the team who led the study, said: "Many patients arrive at A&E in a lot of pain, making these injuries very difficult to assess. Currently, the majority of patients are not referred for follow-up visits to monitor progress or physiotherapy, as clinicians cannot predict who will recover and who would potentially benefit from further care.

"The new SPRAINED tool will provide clinicians with a risk score, supporting their decision-making process when providing advice to people with ankle sprains, and when deciding on ongoing management."

The tool was developed by a team of researchers, clinical practitioners and statisticians, based on data from a previous clinical trial on ankle sprains. SPRAINED was then tested on 682 patients at 10 emergency departments in the UK.

Whilst there are limitations, the research showed that the SPRAINED tool, which uses predictors that are simple to obtain during routine clinical assessment, gave a valuable insight on who could be at higher risk of a poor outcome, namely pain, lack of confidence and ongoing difficulties with the injured ankle.

Similar stories

Adam Croft appointed Norman Collisson Professor of Musculoskeletal Science

This appointment brings a further focus to linking rheumatology discovery science and clinical trials in NDORMS, strengthening translational rheumatology research across the department to deliver transformative treatments for patients with inflammatory arthritis.

NIHR fellowship to support national trial evaluating rehabilitation after kneecap dislocation

Dr Colin Forde has been awarded a National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Postdoctoral Award to lead a national study evaluating rehabilitation for people with a kneecap (patellar) dislocation.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Professor Afsie Sabokbar retires after more than 30 years at NDORMS

Botnar Institute Director of Graduate Studies, Professor Afsie Sabokbar, is retiring after more than 30 years at NDORMS.

Researchers funded to cure – rather than manage – inflammatory disease

Researchers from the Kennedy Institute of Rheumatology will join international partners in a bid to transform how chronic inflammatory disease is treated.

Ghada Alsaleh awarded an Arthritis UK Bridging Fellowship

Professor Ghada Alsaleh has been awarded an Arthritis UK Bridging Fellowship to advance her work studying potential osteoarthritis (OA) treatments.